newsfilter
← Latest News
FDA Approved Drugs·

Approval of Brexafemme, Nda #214900 (Labeling)

Approval Date: 07/24/2026; Drug Name: Brexafemme, Nda #214900; Active Ingredients: IBREXAFUNGERP CITRATE; Company: Glaxosmithkline; Submission Status: Approval; Submission Classification: Labeling; Application Number: 214900

Company
GLAXOSMITHKLINE
Keywords
GLAXOSMITHKLINE